|
10112
|
Imovax Rabies(Pre exposure)
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Sanofi Pasteur
|
2005
|
France
|
All age group
|
3 doses on day 0, 7 and 21
|
Intramuscular
|
NA
|
WISTAR Rabies PM/WI38-1503-3M strain
|
Human diploid cell vaccine
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/imovax
|
|
10113
|
Imovax Rabies(Post exposure)
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Sanofi Pasteur
|
2005
|
France
|
All age group
|
5 doses on day 0, 3, 7, 14 and 28
|
Intramuscular
|
NA
|
WISTAR Rabies PM/WI38-1503-3M strain
|
Human diploid cell vaccine
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/imovax
|
|
10114
|
RabAvert
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Novartis
|
NA
|
NA
|
All age group
|
4 doses on day 0, 3, 7 and 14
|
Intramuscular
|
NA
|
NA
|
Purified chick embryo cell
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref
|
https://www.fda.gov/files/vaccines%2C%20blood%20&%20biologics/published/Package-Insert---RabAvert.pdf
|
|
10115
|
Imogam Rabies-HT
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Sanofi Pasteur
|
NA
|
NA
|
All age group
|
4 doses on day 0, 7 and 21 or 28
|
Intramuscular
|
NA
|
NA
|
Rabies Immunoglobin
|
Government of Canada
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref
|
https://www.sanofi.ca/dam/jcr:21c480e0-afcd-4a38-bfee-fb9b7a6b21e0/imogam-rabies-pasteurized.pdf
|
|
10116
|
HyperRabTM S/D
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Talecris Biotherapeutics Bayer Biological Products
|
NA
|
NA
|
NA
|
NA
|
Intramuscular
|
NA
|
NA
|
Rabies Immunoglobin
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref
|
https://www.hyperrab.com/en/hcp
|
|
10117
|
Verorab
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Sanofi Pasteur
|
2015
|
France
|
NA
|
5 doses on day 0, 3, 7, 14 and 28
|
Intramuscular
|
NA
|
WISTAR Rabies PM/WI38-1503-3M strain
|
Purified vero cell rabies vaccine
|
DCGI
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref
|
https://ncdc.gov.in/WriteReadData/l892s/File557.pdf
|
|
10118
|
Lyssavac N
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Zydus Candila Healthcare Limited
|
NA
|
India
|
NA
|
3 doses on day 0, 7 and 21
|
Intramuscular
|
NA
|
NA
|
Purified duck embryo cell
|
WHO
|
Berna Biotech
|
NA
|
NA
|
NA
|
NA
|
https://www.fda.moph.go.th/sites/drug/Summary/1C_278_50_Lyssavac%20N%20Injection.pdf
|
https://www.livemint.com/Companies/XopdfNnBp4Y6189QY3PY2N/Zydus-Cadila-receives-WHO-nod-for-rabies-vaccine.html
|
|
10119
|
Rabipur
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
GlaxoSmithKline
|
NA
|
NA
|
All age group
|
3 doses on day 0, 7 and 21
|
Intramuscular
|
NA
|
NA
|
Purified chick embryo cell
|
DCGI
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref
|
https://www.wbhealth.gov.in/uploaded_files/IDSP/Guideline_Rabies_prophylaxis_PPT_PDF.pdf
|
|
10120
|
Rabivax-S
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Ross University School of Veterinary Medicine
|
2019
|
India
|
All age group
|
3 doses on day 0, 7 and 21
|
Intramuscular
|
NA
|
NA
|
Human diploid cell vaccine
|
DCGI
|
Serum Institute of India
|
NA
|
NA
|
NA
|
NCT03741270
|
https://clinicaltrials.gov/ct2/show/NCT03741270
|
http://test.pharmabiz.com/news/serum-institute-launches-rabies-vaccine-rabivax-24382
|
|
10121
|
KAMRAB-003
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Live-attenuated
|
Approved
|
Kamada Ltd.
|
2014
|
USA
|
18 - 75 years
|
5 doses on day 0, 3, 7, 14 and 28
|
Intramuscular
|
NA
|
NA
|
NA
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NCT02040090
|
https://clinicaltrials.gov/ct2/show/NCT02040090?cond=Rabies+Human&phase=23&draw=2&rank=5
|
https://pdf.hres.ca/dpd_pm/00048173.PDF
|
|
10122
|
Speeda
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Beijing Center for Disease Control and Prevention
|
2013
|
China
|
NA
|
3 doses on day 0, 7 and 21
|
Intramuscular
|
NA
|
NA
|
NA
|
Thailand FDA
|
NA
|
NA
|
NA
|
NA
|
NCT01821911
|
https://clinicaltrials.gov/ct2/show/NCT01821911?cond=Rabies+Human&phase=23&draw=2&rank=7
|
https://www.immunize.org/askexperts/experts_rab.asp
|
|
10123
|
SA14-14-2 (IXIARO)
|
Viral encephalitis
|
Neurologic
|
West Nile virus
|
positive-sense, single-stranded RNA
|
Live-attenuated
|
Approved
|
Sanofi Pasteur
|
2013
|
Thailand
|
NA
|
NA
|
Subcutaneous
|
NA
|
SA 14-14-2
|
Cell culture based
|
NA
|
NA
|
NA
|
NA
|
24161909
|
NCT01092507
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185882/
|
https://www.fda.gov/media/75777/download
|
|
10124
|
ENCEVAC
|
Viral encephalitis
|
Neurologic
|
West Nile virus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Research Foundation for Microbial Diseases of Osaka University
|
NA
|
NA
|
NA
|
NA
|
Subcutaneous
|
NA
|
Beijing-1(P1)
|
Cell culture based
|
NA
|
NA
|
NA
|
JEBIK V (BIKEN), KD-287, JEIMMUGEN INJ (Kaketsuken)
|
24161909
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185882/
|
https://ifli.wisc.edu/wp-content/uploads/sites/528/2019/05/Japanese-Encephalitis.pdf
|
|
10125
|
IXIARO
|
Viral encephalitis
|
Neurologic
|
West Nile virus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Valneva
|
NA
|
UK
|
2 months and above
|
2 doses 28 days apart
|
Intramuscular
|
Aluminum (aluminium hydroxide)
|
Beijing-3(P3), SA14-14-2
|
Cell culture based
|
US FDA
|
NA
|
New Zealand, Europe, India, China, US, Japan
|
IC51, JESPECT, JEEV (Intercell AG) in Australia
|
24161909
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185882/
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/ixiaro
|
|
10126
|
IMOJEV
|
Viral encephalitis
|
Neurologic
|
West Nile virus
|
positive-sense, single-stranded RNA
|
Live-attenuated
|
Approved
|
Sanofi Pasteur
|
2017
|
Thailand
|
9 months and above
|
3 doses
|
Subcutaneous
|
NA
|
SA 14-14-2
|
Mouse brain based
|
US FDA
|
NA
|
NA
|
ChimeriVax-JE, JE-CV, THAIJEV (Sanofi-Aventis)
|
24161909
|
NCT01900444
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185882/
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/japanese-encephalitis-vaccine-inactivated-adsorbed
|
|
10127
|
IPOL
|
Poliomyelitis
|
Neurologic
|
Poliovirus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Sanofi Pasteur
|
NA
|
NA
|
6 months and above
|
2-3 doses depending on volume and age
|
Intramuscular
|
NA
|
P1, P2 and P3
|
Monkey kidney cell
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/ipol-poliovirus-vaccine-inactivated-monkey-kidney-cell
|
NA
|
|
10128
|
KINRIX
|
Poliomyelitis
|
Neurologic
|
Poliovirus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
GlaxoSmithKline
|
2008
|
NA
|
4 - 6 years
|
5 doses
|
Intramuscular
|
NA
|
P1, P2 and P4
|
NA
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/kinrix
|
NA
|
|
10129
|
PEDIARIX
|
Poliomyelitis
|
Neurologic
|
Poliovirus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
GlaxoSmithKline
|
2002
|
NA
|
6 weeks - 6 years
|
3 doses at regimen of 2, 4, and 6 months of age.
|
Intramuscular
|
NA
|
P1, P2 and P5
|
NA
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/pediarix
|
NA
|
|
10130
|
Pentacel
|
Poliomyelitis
|
Neurologic
|
Poliovirus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Sanofi Pasteur
|
2008
|
NA
|
6 weeks - 4 years
|
4 doses at regimen of 2, 4, 6 and 15-18 months of age
|
Intramuscular
|
NA
|
P1, P2 and P6
|
NA
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/pentacel
|
NA
|
|
10369
|
SYN023 (Freeze-dried Rabies Vaccine for Human Use (Vero Cells))
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
NA
|
Phase 3
|
Synermore Biologics (Suzhou) Co. Ltd.
|
2020
|
China
|
18 years and above
|
5 doses on day 1, 4, 8, 15 and 29
|
Intramuscular
|
NA
|
NA
|
NA
|
US FDA
|
Simoon Record Pharma Information Consulting Co. Ltd., Clinchoice Inc.
|
NA
|
NA
|
NA
|
NCT04644484
|
https://clinicaltrials.gov/ct2/show/NCT04644484?cond=Rabies+Human&phase=23&draw=2&rank=4
|
NA
|
|
10370
|
JE-VAX
|
Viral encephalitis
|
Neurologic
|
West Nile virus
|
positive-sense, single-stranded RNA
|
Live-attenuated
|
Phase 3
|
Research Foundation for Microbial Diseases of Osaka University
|
NA
|
China
|
NA
|
NA
|
Subcutaneous
|
NA
|
Nakayama-NIH/Beijing-1(P1) strain
|
Mouse brain based
|
NA
|
NA
|
Asia
|
SA 14-14-2 vaccine
|
24161909
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185882/
|
NA
|